Lanthio Pharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $21.8M

  • Investors
  • 1

Lanthio Pharma General Information

Description

Operator of a biopharmaceutical company intended to help clients discover and develop therapeutic peptides for severe diseases. The company specializes in applying proprietary lanthionine-peptide drug discovery technology for the generation of novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity, and increased intrinsic activity.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Rozenburglaan 13 B
  • 9727 DL Groningen
  • Netherlands
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • Rozenburglaan 13 B
  • 9727 DL Groningen
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lanthio Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 07-May-2015 $21.8M Completed Clinical Trials - Phase 2
6. Debt - General 21-May-2014 Completed Clinical Trials - Phase 2
5. Early Stage VC (Series A) 27-Nov-2012 Completed Product Development
4. Grant 08-May-2012 Completed Product Development
3. Grant 06-Mar-2012 Completed Product Development
2. Seed Round 01-Jan-2011 Completed Startup
1. University Spin-Out 01-Jan-2010 Completed Startup
To view Lanthio Pharma’s complete valuation and funding history, request access »

Lanthio Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to help clients discover and develop therapeutic peptides for severe di
Other Pharmaceuticals and Biotechnology
Groningen, Netherlands

Basking Ridge, NJ
 

Abingdon, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lanthio Pharma Competitors (33)

One of Lanthio Pharma’s 33 competitors is Lisata Therapeutics, a Corporation company based in Basking Ridge, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lisata Therapeutics Corporation Basking Ridge, NJ
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Aura Biosciences Formerly VC-backed Boston, MA
Arcus Biosciences Formerly VC-backed Hayward, CA
Axsome Therapeutics Formerly VC-backed New York, NY
You’re viewing 5 of 33 competitors. Get the full list »

Lanthio Pharma Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioGeneration Ventures Venture Capital Minority
Hanzepoort Venture Capital Minority
Inkef Venture Capital Minority
RUG Ventures Venture Capital Minority
To view Lanthio Pharma’s complete investors history, request access »

Lanthio Pharma FAQs

  • When was Lanthio Pharma founded?

    Lanthio Pharma was founded in 2010.

  • Where is Lanthio Pharma headquartered?

    Lanthio Pharma is headquartered in Groningen, Netherlands.

  • What industry is Lanthio Pharma in?

    Lanthio Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Lanthio Pharma a private or public company?

    Lanthio Pharma is a Private company.

  • What is the current valuation of Lanthio Pharma?

    The current valuation of Lanthio Pharma is .

  • What is Lanthio Pharma’s current revenue?

    The current revenue for Lanthio Pharma is .

  • How much funding has Lanthio Pharma raised over time?

    Lanthio Pharma has raised $6.12M.

  • Who are Lanthio Pharma’s investors?

    BioGeneration Ventures, Hanzepoort, Inkef, and RUG Ventures have invested in Lanthio Pharma.

  • Who are Lanthio Pharma’s competitors?

    Lisata Therapeutics, Adaptimmune Therapeutics, Aura Biosciences, Arcus Biosciences, and Axsome Therapeutics are some of the 33 competitors of Lanthio Pharma.

  • When was Lanthio Pharma acquired?

    Lanthio Pharma was acquired on 07-May-2015.

  • Who acquired Lanthio Pharma?

    Lanthio Pharma was acquired by MorphoSys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process